PL1812459T3 - Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę - Google Patents

Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę

Info

Publication number
PL1812459T3
PL1812459T3 PL04793596T PL04793596T PL1812459T3 PL 1812459 T3 PL1812459 T3 PL 1812459T3 PL 04793596 T PL04793596 T PL 04793596T PL 04793596 T PL04793596 T PL 04793596T PL 1812459 T3 PL1812459 T3 PL 1812459T3
Authority
PL
Poland
Prior art keywords
mbl
production
cell line
relates
multimeric
Prior art date
Application number
PL04793596T
Other languages
English (en)
Inventor
Hong Mo Moon
Jung Sun Yum
Byung Cheol Ahn
Joo Youn Lee
Jaeseung Yoon
Original Assignee
Dobeel Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dobeel Co Ltd filed Critical Dobeel Co Ltd
Publication of PL1812459T3 publication Critical patent/PL1812459T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4724Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL04793596T 2004-10-28 2004-10-28 Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę PL1812459T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/KR2004/002739 WO2006046786A1 (en) 2004-10-28 2004-10-28 Method for the mass production of multimeric mannose binding lectin
EP04793596A EP1812459B1 (en) 2004-10-28 2004-10-28 Method for the mass production of multimeric mannose binding lectin

Publications (1)

Publication Number Publication Date
PL1812459T3 true PL1812459T3 (pl) 2011-09-30

Family

ID=36228005

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04793596T PL1812459T3 (pl) 2004-10-28 2004-10-28 Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę

Country Status (10)

Country Link
EP (1) EP1812459B1 (pl)
JP (1) JP4592756B2 (pl)
AT (1) ATE503766T1 (pl)
BR (1) BRPI0419151A (pl)
DE (1) DE602004032062D1 (pl)
DK (1) DK1812459T3 (pl)
ES (1) ES2360504T3 (pl)
MX (1) MX2007005107A (pl)
PL (1) PL1812459T3 (pl)
WO (1) WO2006046786A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Hbv 백신 및 그의 제조 방법
JP5071940B2 (ja) * 2008-12-25 2012-11-14 独立行政法人産業技術総合研究所 抗真菌剤
AU2011207626B2 (en) 2010-01-19 2015-06-18 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
EP3081937B1 (en) 2011-07-18 2019-11-13 President and Fellows of Harvard College Engineered microbe-targeting molecules and uses thereof
WO2013130875A1 (en) 2012-02-29 2013-09-06 President And Fellows Of Harvard College Rapid antibiotic susceptibility testing
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3848045A1 (en) 2013-05-21 2021-07-14 President and Fellows of Harvard College Engineered heme-binding compositions and uses thereof
EP3912986B1 (en) 2013-12-18 2023-12-13 President and Fellows of Harvard College Crp capture/detection of bacteria
CN108289928B (zh) 2015-08-06 2024-09-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途
CA3207352A1 (en) 2021-02-08 2022-08-11 Alberto Mantovani Molecules for use in the treatment and/or prevention of covid-19
CN118027168B (zh) * 2024-03-19 2024-08-06 广东现代汉方科技有限公司 基于真核表达的msl重组植物蛋白的制备方法及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337193B1 (en) * 1998-11-24 2002-01-08 Aptagen, Inc. Expression of manose-binding protein in methylotrophic yeast
US6589534B1 (en) * 1999-09-30 2003-07-08 Yeda Research And Development Co., Ltd. Hepatitis B virus binding proteins and uses thereof
KR100408844B1 (ko) * 2000-07-29 2003-12-06 한국산업기술평가원 동물세포 발현벡터
CN101011573A (zh) * 2001-07-23 2007-08-08 纳蒂芒公司 高分子量凝集素的生产
WO2003018617A1 (fr) * 2001-08-31 2003-03-06 Fuso Pharmaceutical Industries, Ltd. Procede de purification de lectine liant le mannose humain, compositions de lectine liant le mannose humain et utilisation medicale de la lectine liant le mannose humain
KR100755931B1 (ko) * 2003-06-11 2007-09-06 (주)두비엘 고분자형 만노스 결합형 렉틴의 대량 생산방법 및 상기방법으로 제조된 만노스 결합형 렉틴 재조합 단백질의제제화

Also Published As

Publication number Publication date
JP4592756B2 (ja) 2010-12-08
ATE503766T1 (de) 2011-04-15
WO2006046786A1 (en) 2006-05-04
DK1812459T3 (da) 2011-05-23
BRPI0419151A (pt) 2007-12-11
EP1812459B1 (en) 2011-03-30
EP1812459A1 (en) 2007-08-01
JP2008517619A (ja) 2008-05-29
EP1812459A4 (en) 2008-10-01
ES2360504T3 (es) 2011-06-06
DE602004032062D1 (de) 2011-05-12
MX2007005107A (es) 2007-09-11

Similar Documents

Publication Publication Date Title
PL1812459T3 (pl) Sposób wytwarzania w skali masowej multimerycznej lektyny wiążącej mannozę
NZ591415A (en) Haemophilus influenzae type B
DE60228460D1 (de) Verfahren zur Herstellung und Reinigung von Erythropoietin
MX2007003906A (es) Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
UA101155C2 (ru) Модифицированный полипептид фактора vii (fvii) и его применение
WO2004098530A3 (en) Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
MX336807B (es) Composiciones y metodos para producir una composicion.
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
DK1317537T3 (da) Sammensætninger og fremgangsmåder med G-CSF analoger
SG149061A1 (en) Definitive endoderm
ATE510005T1 (de) Verfahren zur isolierung von zellen aus der nabelschnur
DE69926647D1 (de) Durch molekulares pathogenicid vermittelte krankheitsresistenz in pflanzen
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
EA200800838A1 (ru) Модуляция иммуностимулирующих свойств короткой интерферирующей рибонуклеиновой кислоты (siphk) с помощью модификации нуклеотидов
WO2006052302A3 (en) Method of producing and purifying adenoviral vectors
WO2006076691A3 (en) Irta-2 antibodies and their uses
NZ603805A (en) Methods for increasing and mobilizing hematopoietic stem cells
WO2020186207A8 (en) Non-viral dna vectors and uses thereof for expressing fviii therapeutics
EP1751282A4 (en) PRODUCTION OF HOST CELLS CONTAINING MULTIPLE INTEGRATED VECTORS THROUGH SERIAL TRANSDUCTION
WO2005097185A3 (en) Irta-5 antibodies and their uses
TW200606177A (en) Glycoprotein VI antibodies and methods thereof
PL1675956T3 (pl) Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
SG156690A1 (en) Mammalian genes involved in infection
MX2022005670A (es) Composiciones y metodos para recombinacion de alta eficiencia de moleculas de arn.
IL138615A0 (en) Alphaviral gene expression system and dna molecules for use therein